单次高剂量局部注射碱性成纤维细胞生长因子改善麻痹后甲杓肌萎缩
该动物研究建立大鼠复发性喉神经麻痹模型,28天后向甲杓肌注射低剂量(200 ng)或高剂量(2,000 ng)碱性成纤维细胞生长因子(bFGF)或生理盐水,结果显示高剂量bFGF组甲杓肌面积随时间增加,治疗28天后显著大于生理盐水对照组(P < .05),作者认为单次高剂量bFGF注射可能临床用于单侧声带麻痹患者。
要点
- 高剂量bFGF(2,000 ng)注射后28天甲杓肌面积显著大于生理盐水对照组(P < .05)。
- Ki67+和Pax7+细胞计数在治疗后第1天最高,MyoD+成肌细胞计数在第7天最高。
- 作者认为单次高剂量bFGF注射可能临床用于单侧声带麻痹患者。
核心结论
- 单次高剂量bFGF注射通过增强肌肉卫星细胞增殖与分化,促进萎缩甲杓肌的再生与分化。
- 作者认为该结果提示bFGF可能临床用于单侧声带麻痹患者。
研究设计与样本
- 动物研究:建立大鼠复发性喉神经麻痹模型,28天后向甲杓肌注射低剂量(200 ng)或高剂量(2,000 ng)bFGF或生理盐水(对照)。
- 治疗后第1、3、7、14、28天切除喉部,比较正常侧与麻痹侧甲杓肌横截面积,并计数Ki67+分裂细胞、Pax7+卫星细胞和MyoD+成肌细胞。
主要发现
- 高剂量bFGF组甲杓肌面积随时间增加,治疗28天后显著大于生理盐水注射对照组(P < .05)。
- Ki67+和Pax7+细胞计数在治疗后第1天最高,MyoD+成肌细胞计数在第7天最高。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Unilateral vocal fold paralysis (UVFP) induces hoarseness due to progressive atrophy of the denervated thyroarytenoid (TA) muscle. Therefore, treatments aimed at regenerating the atrophied TA muscle are required. Basic fibroblast growth factor (bFGF) is involved in muscle development and regeneration. This study aimed to elucidate the effects of bFGF injection on atrophied TA muscle. STUDY DESIGN: Animal research. METHODS: A recurrent laryngeal nerve-paralysis rat model was established, and low- (200 ng) or high-dose (2,000 ng) bFGF or saline (control) was injected into the TA muscle 28 days later. The larynges were excised on day 1, 3, 7, 14, and 28 after treatment. The cross-sectional area of the TA muscle in normal and paralyzed sides was compared, and the Ki67-positive (Ki67+ ) dividing cells, paired box 7-positive (Pax7+ ) satellite cells (SCs), and myogenic differentiation-positive (MyoD+ ) myoblasts were counted. RESULTS: The TA muscle area of animals administered high-dose bFGF increased with time and was significantly larger than that of the saline-injected controls 28 days after treatment (P < .05). The counts of Ki67+ and Pax7+ cells were the highest on day 1, whereas the MyoD+ myoblast count was highest on day 7. These results suggest that bFGF administration into the denervated TA muscles compensated for the atrophied TA muscles by inducing proliferation of SCs and their differentiation to myoblasts. CONCLUSIONS: A single injection of high-dose bFGF augmented regeneration and differentiation of the atrophied TA muscle by enhancing proliferation and differentiation of muscle SCs, suggesting its possible clinical application in humans with UVFP. LEVEL OF EVIDENCE: NA Laryngoscope, 130:159-165, 2020.
引用
- Goto T, Ueha R, Sato T, et al. Single, high-dose local injection of bFGF improves thyroarytenoid muscle atrophy after paralysis. Laryngoscope. 2019. PMID: 30810241. doi:10.1002/lary.27887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。